Nivolumab vs Trazodone
Nivolumab vs Trazodone: Overview
This comparison examines the pharmacological differences between Nivolumab and Trazodone.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Trazodone: Serotonin antagonist and reuptake inhibitor (SARI).
Pharmacokinetics
Half-life: Nivolumab — 27 days; Trazodone — 5-9 hours.
Chemical Properties
Molecular Formula: Trazodone — C19H22ClN5O.
Molecular Weight: Trazodone — 371.8640 g/mol.
Type: Nivolumab — Antibody; Trazodone — Small molecule.